MedPath

Safety and Performance of a New Coating for Urinary Intermittent Catheters

Not Applicable
Completed
Conditions
Intermittent Urethral Catheterization
Interventions
Device: ZN-D catheter
Device: ZN-C catheter
Device: SpeediCath catheter
Registration Number
NCT01800903
Lead Sponsor
Coloplast A/S
Brief Summary

The aim of the study is to evaluate safety and performance of a new catheter coating,compared to the current SpeediCath coating.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
40
Inclusion Criteria
  1. Have given written informed consent and signed letter of authority
  2. Be at least 18 years of age and have full legal capacity
  3. Be a male
  4. Willing to refrain from using analgetics up to 24 hours prior to catheterization visits
Exclusion Criteria
  1. Abnormalities, diseases or surgical procedures performed in the lower urinary tract
  2. Symptoms of urinary tract infections (at least one of the following: frequent urination, stinging or pain at urination)
  3. Participating in other interventional clinical investigations during this investigation (inclusion to termination) or have previously participated in this investigation (including run-in period)
  4. Known hypersensitivity toward any of the test products -

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Sequence 6SpeediCath catheterZN-C catheter then ZN-D catheter then SpeediCath catheter
Sequence 2ZN-C catheterSpeediCath catheter then ZN-C catheter then ZN-D catheter
Sequence 5ZN-D catheterZN-C catheter then SpeediCath catheter then ZN-D catheter
Sequence 2ZN-D catheterSpeediCath catheter then ZN-C catheter then ZN-D catheter
Sequence 1SpeediCath catheterSpeediCath catheter then ZN-D catheter then ZN-C catheter
Sequence 3ZN-D catheterZN-D catheter then SpeediCath catheter then ZN-C catheter
Sequence 1ZN-D catheterSpeediCath catheter then ZN-D catheter then ZN-C catheter
Sequence 1ZN-C catheterSpeediCath catheter then ZN-D catheter then ZN-C catheter
Sequence 2SpeediCath catheterSpeediCath catheter then ZN-C catheter then ZN-D catheter
Sequence 3ZN-C catheterZN-D catheter then SpeediCath catheter then ZN-C catheter
Sequence 4ZN-C catheterZN-D catheter then ZN-C catheter then SpeediCath catheter
Sequence 4SpeediCath catheterZN-D catheter then ZN-C catheter then SpeediCath catheter
Sequence 6ZN-C catheterZN-C catheter then ZN-D catheter then SpeediCath catheter
Sequence 3SpeediCath catheterZN-D catheter then SpeediCath catheter then ZN-C catheter
Sequence 4ZN-D catheterZN-D catheter then ZN-C catheter then SpeediCath catheter
Sequence 5ZN-C catheterZN-C catheter then SpeediCath catheter then ZN-D catheter
Sequence 5SpeediCath catheterZN-C catheter then SpeediCath catheter then ZN-D catheter
Sequence 6ZN-D catheterZN-C catheter then ZN-D catheter then SpeediCath catheter
Primary Outcome Measures
NameTimeMethod
Overall Discomfort During Catheterization1 day

Evaluated by the subject on a 10 cm Visual Analog Scale (VAS), where 0 cm is no discomfort and 10 cm is the worst possible discomfort.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Urology

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath